MannKind
Likely to Engage tag.Highly Engaged Employees

Manufacturing · Connecticut, United States · 501-1,000 Employees

View Company Info for Free

Overview

Headquarters

1 Casper St, Danbury, Connecticut, 06810...

Phone Number

(818) 661-5000

Revenue

$393.6 Million

Stock Symbol

MNKD

Industry

Manufacturing Pharmaceuticals Business Services Research & Development Medical Devices & Equipment

About MannKind

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States. It offers Afrezza Inhalation Powder, an inhaled insulin used to improve glycemic control in adults with diabetes; the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults; and Tyvaso DPI for the treatment of pulmonary arterial hypertension and pulmonary hypertension.Explore more
MannKind's Social MediaSIC Code 38,384NAICS Code 32,325Ticker NASDAQ: MNKDShow more

MannKind Org Chart

PhoneEmail
Chris Prentiss, Chief Financial Officer at MannKind
United States flag for contact location.

Chief Financial Officer

PhoneEmail
RN
United States flag for contact location.

Chief Financial Officer

PhoneEmail
Ajay Ahuja, Chief Medical Officer at MannKind
United States flag for contact location.

Chief Medical Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
JR
United States flag for contact location.

Vice President, Finance & Corporate Controlle...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to MannKind

Compare insights from companies similar to MannKind, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

MannKind

$393.6M
501-1,000
Public
$1.7B
1991
Chris Prentiss, Chief Financial Officer at MannKind
Chris PrentissChief Financial Officer
$1.1B
1K - 5K
Public
$775M
1988
William Lewis, Chairman & Chief Executive Officer at Insmed
William LewisChairman & CEO
$120.8M
201-500
Public
$140M
1979
JS
Joseph StichPresident, In Vitro Diagnostics
$120.7M
201-500
Public
-
1983
TF
Thomas FinnertyChief Human Resources Officer
$101.3M
201-500
Private
-
1987
Naruhito Higo, Chief Executive Officer & Chairman at Noven
Naruhito HigoCEO & Chairman
$52.1M
201-500
Public
$372.7M
2006
Pravin Dugel, Executive Chair, President, and Chief Executive Officer at Ocular Therapeutix
Pravin DugelExecutive Chair, President, and CEO
$51M
201-500
Private
-
1994
AG
Alycia GreneskoManager, Conference Content and Speaker Relations
Illustration of an envelope

MannKind Tech Stack

A closer look at the technologies used by MannKind

Top Manufacturing Companies

Frequently Asked Questions Regarding MannKind

What is MannKind's stock symbol?
MannKind's stock symbol is MNKD
What is MannKind's official website?
MannKind's official website is www.mannkindcorp.com
What is MannKind's Revenue?
MannKind's revenue is $393.6 Million
What is MannKind's SIC code?
MannKind's SIC: 38,384
What is MannKind's NAICS code?
MannKind's NAICS: 32,325
How many employees does MannKind have?
MannKind has 501-1,000 employees
What industry does MannKind belong to?
MannKind is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is MannKind competition?
MannKind top competitors include: Ocular Therapeutix, Anika Therapeutics, Insmed, Surmodics
What companies has MannKind acquired?
MannKind has acquired the companies: Qrumpharma
What technology does MannKind use?
Some of the popular technologies that MannKind uses are: Freshservice, Zingfit, WordPress.org, iCIMS
Who is the CFO of MannKind?
MannKind's CFO is Chris Prentiss
What does MannKind do?

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States. It offers Afrezza Inhalation Powder, an inhaled insulin used to improve glycemic control in adults with diabetes; the V-Go wearable insulin delivery dev... ice, which provides continuous subcutaneous infusion of insulin in adults; and Tyvaso DPI for the treatment of pulmonary arterial hypertension and pulmonary hypertension.Read More

What are MannKind social media links?
MannKind Linkedin page MannKind Twitter page MannKind Facebook page
Who invested in MannKind?
MannKind has 14 investors including Frazier Life Sciences Management, PPP, Sanofi and Deerfield Management.
Is MannKind a public company?
Yes, MannKind is a public company and is traded under the symbol MNKD
See more information about MannKind

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.